Dr. Fadi A. El Atat, MD

Dr. El Atat practices at Fa Cv Consultants in Union, New Jersey.

Dr. El Atat's NPI, 1386776797, was assigned on March 12, 2007. Dr. El Atat graduated from American University of Beirut Faculty of Medicine in 1999. Dr. El Atat holds New Jersey license 25MA08676700.

Dr. El Atat's primary practice is Fa Cv Consultants, at 1945 Morris Ave, Union, NJ 07083 in Union County. The practice phone is (973) 744-4075.

Dr. El Atat's primary practice is Fa Cv Consultants in Union, New Jersey. Dr. El Atat is also affiliated with Cooperman Barnabas Medical Center. The medical group on file is FA CV Consultants P.C. Dmand AI also links Dr. El Atat to 2 more hospitals, 2 group practices and clinics, 2 home health agencies and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. El Atat practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. El Atat's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. El Atat's licenses on file in 2 states: New Jersey and Ohio.

CMS data shows 2,180 Medicare services from Dr. El Atat across 18 procedure codes in 2024, for 325 Medicare patients. Medicare paid $233,148 for them.

CMS counts 325 Medicare patients who saw Dr. El Atat in 2024. The largest group is 65 to 74, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. El Atat's median patient age at 57, with 50% women.

In 2024, Dr. El Atat wrote 7,780 Medicare Part D claims for 769 patients. 83% of them were for generic drugs. CMS names the drug for 7,043 of them, across 116 drugs with 11 or more claims each, at $948,986 in total drug cost. In 2023, CMS named 7,796 claims across 119 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 26 out of 100 for Dr. El Atat for performance year 2024, reported individually. Dr. El Atat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 54 procedures of coronary angioplasty and stenting by Dr. El Atat, more than 86% of the clinicians it reports for that procedure.

CMS Open Payments shows 905 general payments to Dr. El Atat from 58 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,699.

Dr. El Atat graduated from American University of Beirut Faculty of Medicine in 1999.